Tara Gomes, epidemiologist in Ontario, Canada, speaks to enlightening research that larger quantities of take home Buprenorphine and methadone, and as such are multi-day dose packets, can be safe and productive in stabilized patients. The project was partially in response to covid caused travel restrictions. Some of the results was that this strategy reduced barriers, the fears of increased overdoses were unfounded, and it maintained treatment. This is like the U.S. methadone maintenance clinic model but within the Canadian structure.